Co-Diagnostics (CODX) Reports FY Loss of $1.20

Co-Diagnostics (NASDAQ: CODX) reported FY EPS of ($1.20). Revenue for the period came in at $6.8 million.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• General Mills (GIS) PT Lowered to $42 at Freedom Broker
• Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank